Transcription and Chromatin – Virtual

Overview

Registered participants for the virtual conference were sent final details, including links to virtual platforms, on Thursday 20 August. The link to the live stream will be sent on Wednesday 26 August.

Abstract submission for this conference is closed. For late registration enquiries, please contact Raili Pall.

EMBL is committed to sharing research advances and sustaining scientific interaction throughout the coronavirus pandemic. We are delighted to announce that the conference is going virtual and invite you to join us online. The virtual conference includes talks from invited speakers, short talk presenters, digital poster sessions and networking opportunities.

Conference Overview

The EMBL Transcription and Chromatin meeting has a long-standing tradition in shaping the field of transcriptional regulation. The meeting brings together leading experts covering all aspects of transcription including cis-regulatory function, long range regulation, 3-dimensional looping, the basal transcriptional machinery, RNA polymerase regulation and function, nucleosome positioning, chromatin modifications, chromatin remodelling and epigenetic inheritance of transcriptional silencing. The meeting contains many talks selected from the abstracts that are interspersed with invited speakers, discussing the latest breakthroughs in transcriptional regulation.

The conference is designed to promote interactive discussions at both the talks and poster sessions. Given the excellent line up of speakers and the meeting’s outstanding reputation, this is a ‘must’ attend for anyone interested in cutting edge research in transcription.

Session Topics

• Activators, enhancer function, evolution and modelling
• Long range transcriptional regulation and enhancers
• General basal transcriptional machinery
• Pol II function, pausing and the role of RNA in transcription
• Chromatin modifications and transcription
• Transcriptional regulation during cell fate decisions – stem cell reprogramming and normal embryonic development
• Genome topology and three-dimensional regulation
• Single cell quantification

What past participants say about the conference:

“I had a great time at EMBL Transcription and Chromatin. I enjoyed the variety of topics covered in the talks and I got a lot of input during the poster session. I hope one day I can also give a talk at this conference!” – Laura Breimann, Max Delbrück Center for Molecular Medicine, Germany

“This was certainly the most exciting meeting I have ever attended. The EMBL respires science of excellence. I will be back!” – Marcelo Fantappie, Rio de Janeiro Federal University, Brazil

“The EMBL Transcription and Chromatin Conference 2018 was excellent. It provided me with an invaluable opportunity to network, discuss my research with experts and learn a lot about the cutting edge research in the field. I feel very lucky to have had the opportunity to attend this conference.” – Katrina Mitchell, Peter MacCallum Cancer Centre, Australia

Speakers and Organisers

Asifa Akhtar

Max Planck Institute of Immunobiology and Epigenetics,

Germany

Shelley L. Berger

University of Pennsylvania,

USA

Alistair Boettiger

Stanford University,

USA

Steve Buratowski

Harvard Medical School,

USA

Zhucheng Chen

Tsinghua University,

China

Patrick Cramer

Max Planck Institute for Biophysical Chemistry,

Germany

Wouter de Laat

Hubrecht Institute,

The Netherlands

Luciano Di Croce

Centre for Genomic Regulation,

Spain

Denis Duboule

University of Geneva and École Polytechnique Fédérale de Lausanne,

Switzerland

Beat Fierz

École Polytechnique Fédérale de Lausanne,

Switzerland

David Gilmour

The Pennsylvania State University,

USA

Anja Groth

University of Copenhagen,

Denmark

Steven Henikoff

Fred Hutchinson Cancer Research Center,

USA

Torben Heick Jensen

Aarhus University,

Denmark

Robert Kingston

Harvard Medical School,

USA

Claudia Köhler

Swedish University of Agricultural Sciences,

Sweden

Mitzi I. Kuroda

Harvard Medical School,

USA

Daniel R. Larson

National Cancer Institute,

USA

Karolin Luger

University of Colorado Boulder,

USA

Christoph Müller

EMBL Heidelberg,

Germany

Gioacchino Natoli

Humanitas University,

Italy

Ana Pombo

Max Delbrück Center for Molecular Medicine,

Germany

Danny Reinberg

Howard Hughes Medical Institute at NYU Langone School of Medicine,

USA

Ali Shilatifard

Northwestern University Feinberg School of Medicine,

USA

David Shore

University of Geneva,

Switzerland

Azim Surani

Wellcome Trust/CRUK Gurdon Institute,

UK

Jesper Svejstrup

The Francis Crick Institute,

UK

Marc Timmers

University of Freiburg and German Cancer Research Centre,

Germany

Cynthia Wolberger

Johns Hopkins University School of Medicine,

USA

Joanna Wysocka

Stanford University,

USA

Scientific Organiser

Karen Adelman

Harvard Medical School,

USA

Eileen Furlong

EMBL Heidelberg,any

Germany

Jürg Müller

Max Planck Institute of Biochemistry,

Germany

Peter Verrijzer

Erasmus University Medical Center,

The Netherlands

Conference Organisers

Raili Pall

EMBL Heidelberg

Germany

Nathalie Sneider

EMBL Heidelberg

Germany

Programme